Industrial Manufacturing Process for Boc-D-Ser(Bzl)-OH
- High Yield Synthesis: Optimized benzylation protocols ensure consistent reaction yields exceeding 95%.
- Strict Quality Control: Final product maintains industrial purity ≥99% with comprehensive COA documentation.
- Bulk Scalability: Robust supply chain capabilities support large-scale pharmaceutical intermediate procurement.
The production of protected amino acids is a cornerstone of modern peptide chemistry. Specifically, Boc-D-Ser(Bzl)-OH (CAS: 47173-80-8) serves as a critical chiral building block for the assembly of complex therapeutic peptides. As a global manufacturer dedicated to fine chemical excellence, understanding the intricacies of the manufacturing process is essential for ensuring batch-to-batch consistency and cost-effectiveness in large-scale operations.
This technical overview details the raw material sourcing, reaction optimization, and environmental compliance standards required to produce high-quality O-Benzyl-N-(tert-butoxycarbonyl)-D-serine. By adhering to rigorous synthetic protocols, producers can mitigate impurities such as over-benzylated byproducts or racemization issues that compromise downstream synthesis.
Raw Material Sourcing for Large Scale Production
The foundation of a robust synthesis route lies in the quality of starting materials. For the production of tert-butyloxycarbonyl-O-benzyl-D-serine, the primary precursors are D-Serine and di-tert-butyl dicarbonate (Boc2O), followed by benzylation agents. Sourcing enantiomerically pure D-Serine is paramount, as any contamination with the L-enantiomer can be detrimental to the biological activity of the final peptide drug.
Industrial scale production requires securing bulk quantities of benzyl bromide or benzyl chloride under strict safety regulations. The stability of the Boc protecting group allows for long-term storage of intermediates, reducing waste during the supply chain logistics. When evaluating suppliers, procurement officers should prioritize vendors who can provide a full COA (Certificate of Analysis) detailing optical rotation and chiral purity. This ensures that the stereochemistry remains intact throughout the protection steps.
Optimization of Reaction Conditions for Yield
The core chemical transformation involves the protection of the hydroxyl group on the serine side chain while maintaining the integrity of the N-terminal Boc group. A common and efficient method involves the cesium carbonate-mediated benzylation of N-Boc-D-serine. This process leverages the reactivity of the hydroxyl group while the amine and carboxyl groups remain protected.
Alternatively, a multi-step reaction sequence may be employed using sodium hydride in N,N-dimethyl-formamide (DMF) at controlled low temperatures (e.g., -40 °C). Precise temperature control is critical to prevent side reactions such as epimerization. The resulting product typically boasts high industrial purity (≥99%), a critical factor for its use as a pharmaceutical intermediate.
Optimization focuses on maximizing yield while minimizing solvent usage. Reaction monitoring via HPLC ensures that the conversion is complete before quenching. For clients looking to secure reliable supply chains, understanding these technical parameters is vital. When sourcing high-purity N-Boc-O-Benzyl-D-serine, buyers should verify that the manufacturer employs these optimized conditions to guarantee low impurity profiles.
Key Physical and Chemical Attributes
The final active pharmaceutical ingredient (API) intermediate must meet specific physical standards. BOC-SER(BZL)-OH typically appears as a white crystalline powder. The presence of the Boc group allows for acid-labile deprotection, a technique widely employed in peptide synthesis using trifluoroacetic acid (TFA). The benzyl group on the hydroxyl moiety offers orthogonal protection, meaning it can be removed independently under different conditions, often via hydrogenolysis.
These properties make N-t-BOC-O-benzyl-D-serine a versatile building block for solid-phase peptide synthesis (SPPS). The Boc/Bzl strategy remains relevant despite the rise of Fmoc chemistry, particularly for sequences requiring high stability during acidolytic cleavage or specific hydrogenation steps.
Environmental Compliance and Waste Management Protocols
Modern chemical manufacturing must adhere to strict environmental, health, and safety (EHS) standards. The use of solvents like DMF and reagents such as sodium hydride requires specialized waste treatment protocols. Effective waste management involves the recovery and recycling of solvents where possible to reduce the environmental footprint and lower the overall bulk price of the product.
Neutralization of acidic and basic waste streams is conducted before disposal to comply with local regulations. Furthermore, dust control systems are implemented during the packaging of fine powders to ensure worker safety. A responsible manufacturer prioritizes green chemistry principles, aiming to reduce the E-factor (mass of waste per mass of product) through continuous process improvement.
Technical Specifications Table
The following table outlines the standard quality parameters expected from a top-tier supplier like NINGBO INNO PHARMCHEM CO.,LTD.
| Parameter | Specification |
|---|---|
| Product Name | N-Boc-O-Benzyl-D-serine |
| CAS Number | 47173-80-8 |
| Molecular Formula | C15H21NO5 |
| Molecular Weight | 295.33 g/mol |
| Purity (HPLC) | ≥ 99.0% |
| Appearance | White to Off-White Powder |
| Optical Rotation | Specific rotation consistent with D-enantiomer |
Conclusion
The industrial production of protected amino acids requires a balance of precise synthetic chemistry and scalable engineering. By focusing on optimized reaction conditions and strict quality control, manufacturers can deliver intermediates that meet the demanding standards of the pharmaceutical industry. NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier partner for these requirements, offering technical expertise and reliable bulk supply capabilities.
Whether for research and development or commercial scale production, selecting a supplier with a proven track record in handling chiral intermediates is essential. The versatility of this compound in constructing complex chiral molecules ensures its continued demand in the synthesis of novel therapeutic agents.